16/02/12

Fresenius Chooses KRUK as 2012 Charity

Kidney charity and dialysis provider join forces to save lives

A national kidney charity has joined forces with a leading global dialysis company, combining cutting-edge research with life-saving treatment to help improve the lives of the thousands of people afflicted by a currently incurable disease.

Kidney Research UK, the largest funder dedicated to kidney research and kidney problems in the United Kingdom, has been chosen by Fresenius Medical Care Renal Services Ltd as the charity they will support during 2012.

With over three million people in the UK at risk of kidney disease, Fresenius – with its 56 dialysis units providing high quality care to nearly 4,000 NHS kidney patients in the UK – is hoping to raise the vital cash needed to help make a brighter future for thousands of kidney patients, by finding better treatments and ultimately a cure for the disease.

Kidney disease has, in recent years, become an epidemic in the UK. The illness can affect anyone at any age and is often referred to as the silent killer because commonly it presents few symptoms until the disease is advanced.

Charles Kernahan, Chief Executive of Kidney Research UK said: “We’re delighted that Fresenius Medical Care has chosen us as their Charity of the Year. Our work directly benefits the very patients in Fresenius’ care and therefore this adoption is a perfect fit. We look forward to Fresenius helping us in our vision of a world free from kidney disease.”

Midlands-based Fresenius will kick start its fundraising activities on World Kidney Day on the 8 March this year, with a number of events involving staff, patients and volunteers at many of their dialysis units.

As well as raising much needed funds to help the estimated 50,000 people in the UK being treated for end-stage renal failure, Fresenius plan to help Kidney Research UK spread the word about kidney disease, highlighting the risks to the general public.

Christine Houghton, Managing Director of Fresenius Medical Care Renal Services Ltd said: “We are pleased to be supporting Kidney Research UK on this important issue of raising awareness of kidney disease. As the largest independent provider of dialysis treatments to NHS patients, we understand the impact of end-stage renal failure on patients’ quality of life.  We are continually striving to ensure that all patients have access the best innovative treatments and services.

For further information please visit the Kidney Research UK Website.